ArticleInternational cancer conference journal2022
A case of recurrent refractory cervical primary histiocytic sarcoma treated with pembrolizumab.
Yu Furui et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this papercites it